From Yahoo Finance: 2025-05-12 08:31:00

Diamond Hill Capital released its first-quarter 2025 investor letter, showing a mixed market performance with a 1.36% return, trailing the Russell 1000 Value Index benchmark. The top 5 positions for 2025 can be found in the letter.

Abbott Laboratories (NYSE: ABT) was highlighted in the letter, with a 5.01% one-month return and a 27.21% gain over the last 52 weeks. The stock closed at $133.24 per share on May 9, 2025, with a market cap of $231.816 billion.

In Q1, Abbott Laboratories (NYSE: ABT) was a top contributor to the fund’s performance, executing well and receiving European approval for its Volt Pulse Field Ablation (PFA) system.

Abbott Laboratories (NYSE: ABT) is not among the 30 most popular stocks among hedge funds, but 66 hedge fund portfolios held it at the end of Q4. While the stock has potential, AI stocks are seen as holding greater promise for higher returns in a shorter timeframe.



Read more at Yahoo Finance: Abbott Laboratories (ABT) Benefitted From Better Execution